Human Genome Epidemiology Literature Finder
|
Records 1 - 20 (of 20 Records) |
| Query Trace: Syndrome and SETBP1[original query] |
|---|
| Somatic SETBP1 mutations in myeloid malignancies. Nature genetics 2013 Aug 45 (8): 942-6. Makishima Hideki, Yoshida Kenichi, Nguyen Nhu, Przychodzen Bartlomiej, Sanada Masashi, Okuno Yusuke, Ng Kwok Peng, Gudmundsson Kristbjorn O, Vishwakarma Bandana A, Jerez Andres, Gomez-Segui Ines, Takahashi Mariko, Shiraishi Yuichi, Nagata Yasunobu, Guinta Kathryn, Mori Hiraku, Sekeres Mikkael A, Chiba Kenichi, Tanaka Hiroko, Muramatsu Hideki, Sakaguchi Hirotoshi, Paquette Ronald L, McDevitt Michael A, Kojima Seiji, Saunthararajah Yogen, Miyano Satoru, Shih Lee-Yung, Du Yang, Ogawa Seishi, Maciejewski Jaroslaw |
| Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progression. American journal of hematology 2014 Feb 89 (2): 181-6. Hou Hsin-An, Kuo Yuan-Yeh, Tang Jih-Luh, Chou Wen-Chien, Yao Ming, Lai Yan-Jun, Lin Chien-Chin, Chen Chien-Yuan, Liu Chieh-Yu, Tseng Mei-Hsuan, Huang Chi-Fei, Chiang Ying-Chieh, Lee Fen-Yu, Liu Ming-Chih, Liu Chia-Wen, Huang Shang-Yi, Ko Bor-Sheng, Wu Shang-Ju, Tsay Woei, Chen Yao-Chang, Tien Hwei-Fa |
| Dynamics of ASXL1 mutation and other associated genetic alterations during disease progression in patients with primary myelodysplastic syndrome. Blood cancer journal 2014 4 e177. Chen T-C, Hou H-A, Chou W-C, Tang J-L, Kuo Y-Y, Chen C-Y, Tseng M-H, Huang C-F, Lai Y-J, Chiang Y-C, Lee F-Y, Liu M-C, Liu C-W, Liu C-Y, Yao M, Huang S-Y, Ko B-S, Hsu S-C, Wu S-J, Tsay W, Chen Y-C, Tien H |
| Impact of TET2, SRSF2, ASXL1 and SETBP1 mutations on survival of patients with chronic myelomonocytic leukemia. Experimental hematology & oncology 2015 4 14. Cui Yajuan, Tong Hongyan, Du Xin, Li Bing, Gale Robert Peter, Qin Tiejun, Liu Jinqin, Xu Zefeng, Zhang Yue, Huang Gang, Jin Jie, Fang Liwei, Zhang Hongli, Pan Lijuan, Hu Naibo, Qu Shiqiang, Xiao Zhiji |
| Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2016 May . Wang Sa A, Tam Wayne, Tsai Albert G, Arber Daniel A, Hasserjian Robert P, Geyer Julia T, George Tracy I, Czuchlewski David R, Foucar Kathryn, Rogers Heesun J, Hsi Eric D, Bryan Rea B, Bagg Adam, Dal Cin Paola, Zhao Chong, Kelley Todd W, Verstovsek Srdan, Bueso-Ramos Carlos, Orazi Attil |
| Application of chromosome microarray analysis in patients with unexplained developmental delay/intellectual disability in South China. Pediatrics and neonatology 2018 Mar . Wang Rongyue, Lei Tingying, Fu Fang, Li Ru, Jing Xiangyi, Yang Xin, Liu Juan, Li Dongzhi, Liao C |
| SETBP1 mutations in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome. Pathology, research and practice 2018 Mar . Yao Xin-Yu, Zhou Jing-Dong, Yang Jing, Zhang Wei, Ma Ji-Chun, Wen Xiang-Mei, Yao Dong-Ming, Xu Zi-Jun, Wu De-Hong, He Pin-Fang, Qian Jun, Lin Jia |
| Exome Sequencing in BRCA1- and BRCA2-Negative Greek Families Identifies MDM1 and NBEAL1 as Candidate Risk Genes for Hereditary Breast Cancer. Frontiers in genetics 2019 10 1005. Glentis Stavros, Dimopoulos Alexandros C, Rouskas Konstantinos, Ntritsos George, Evangelou Evangelos, Narod Steven A, Mes-Masson Anne-Marie, Foulkes William D, Rivera Barbara, Tonin Patricia N, Ragoussis Jiannis, Dimas Antigone |
| Juvenile myelomonocytic leukemia - A bona fide RASopathy syndrome. Best practice & research. Clinical haematology 2020 5 33 (2): 101171. Lasho Terra, Patnaik Mrinal |
| Differential U2AF1 mutation sites, burden and co-mutation genes can predict prognosis in patients with myelodysplastic syndrome. Scientific reports 2020 10 10 (1): 18622. Wang Haiqiong, Guo Yongbo, Dong Zhenkun, Li Tao, Xie Xinsheng, Wan Dingming, Jiang Zhongxing, Yu Jifeng, Guo Ro |
| Concomitant isochromosome 17q and mutated SETBP1 in a myelodysplastic syndrome patient with a poor prognosis. International journal of clinical and experimental pathology 2020 1 10 (9): 9786-9792. Xu Qian, Liu Chunxia, Zhang Hao, Liu Huan, Xue Mingming, Zhang Shuling, Liu B |
| Gender-related differences in the outcomes and genomic landscape of patients with myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes. British journal of haematology 2021 May . Karantanos Theodoros, Gondek Lukasz P, Varadhan Ravi, Moliterno Alison R, DeZern Amy E, Jones Richard J, Jain Tan |
| Identification of SETBP1 Mutations by Gene Panel Sequencing in Individuals With Intellectual Disability or With "Developmental and Epileptic Encephalopathy". Frontiers in neurology 2021 1 11 593446. Leonardi Emanuela, Bettella Elisa, Pelizza Maria Federica, Aspromonte Maria Cristina, Polli Roberta, Boniver Clementina, Sartori Stefano, Milani Donatella, Murgia Alessand |
| Clinical and Molecular Determinants of Clonal Evolution in Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2022 9 41 (1): 132-142. Gurnari Carmelo, Pagliuca Simona, Prata Pedro Henrique, Galimard Jacques-Emmanuel, Catto Luiz Fernando B, Larcher Lise, Sebert Marie, Allain Vincent, Patel Bhumika J, Durmaz Arda, Pinto Andre L, Inacio Mariana C B, Hernandez Lucie, Dhedin Nathalie, Caillat-Zucman Sophie, Clappier Emmanuelle, Sicre de Fontbrune Flore, Voso Maria Teresa, Visconte Valeria, Peffault de Latour Régis, Soulier Jean, Calado Rodrigo T, Socié Gérard, Maciejewski Jaroslaw |
| Effect of mutation allele frequency on the risk stratification of myelodysplastic syndrome patients. American journal of hematology 2022 9 97 (12): 1589-1598. Lee Wan-Hsuan, Lin Chien-Chin, Tsai Cheng-Hong, Tseng Mei-Hsuan, Kuo Yuan-Yeh, Liu Ming-Chih, Tang Jih-Luh, Sun Hsun-I, Chuang Yi-Kuang, Chou Wen-Chien, Hou Hsin-An, Tien Hwei-Fa |
| Genomic landscape of myelodysplastic/myeloproliferative neoplasm can predict response to hypomethylating agent therapy. Leukemia & lymphoma 2022 4 63 (8): 1942-1948. Karantanos Theodoros, Tsai Hua-Ling, Gondek Lukasz P, DeZern Amy E, Ghiaur Gabriel, Dalton W Brian, Gojo Ivana, Prince Gabrielle T, Webster Jonathan, Ambinder Alexander, Smith B Douglas, Levis Mark J, Varadhan Ravi, Jones Richard J, Jain Tan |
| The clinical and molecular spectrum of ETV6 mutated myeloid neoplasms. British journal of haematology 2023 5 . Mark Gurney, Ismahene Chekkaf, Anmol Baranwal, Rami Basmaci, Bahga Katamesh, Patricia Greipp, James M Foran, Talha Badar, Abhishek A Mangaonkar, Kebede H Begna, Naseema Gangat, Mrinal M Patnaik, Mark R Litzow, Mithun V Shah, David S Viswanatha, Rong He, Hassan B Alkhateeb, Aref Al-Ka |
| Genomic Landscape of Myelodysplastic/Myeloproliferative Neoplasms: A Multi-Central Study. International journal of molecular sciences 2024 9 25 (18): . Fei Fei, Amar Jariwala, Sheeja Pullarkat, Eric Loo, Yan Liu, Parastou Tizro, Haris Ali, Salman Otoukesh, Idoroenyi Amanam, Andrew Artz, Feras Ally, Milhan Telatar, Ryotaro Nakamura, Guido Marcucci, Michelle Afkha |
| Prognostic impact of DTA mutation and co-occurring mutations in patients with myelodysplastic syndrome. Molecular biology reports 2024 9 51 (1): 985. Min Wang, Ping Chen, Daqi Li, Mingfeng Zh |
| Prognostic mutations identified by whole-exome sequencing and validation of the Molecular International Prognostic Scoring System in myelodysplastic syndromes after allogeneic haematopoietic stem cell transplantation. British journal of haematology 2024 8 . Hong Wang, Xueqian Li, Jiaqian Qi, Hong Liu, Tiantian Chu, Xiaoyan Xu, Huiying Qiu, Chengcheng Fu, Xiaowen Tang, Changgeng Ruan, Depei Wu, Yue H |
- Page last reviewed:Feb 1, 2024
- Content source: